SageView Advisory Group’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$584K Sell
7,464
-541
-7% -$43.6K 0.02% 336
2026
Q1
$694K Sell
8,005
-15,510
-66% -$1.49M 0.03% 283
2025
Q4
$2.26M Sell
23,515
-689
-3% -$66.9K 0.08% 139
2025
Q3
$2.31M Buy
24,204
+15,062
+165% +$1.38M 0.08% 142
2025
Q2
$841K Sell
9,142
-41
-0.4% -$3.48K 0.03% 267
2025
Q1
$825K Sell
9,183
-826
-8% -$73.9K 0.04% 254
2024
Q4
$800K Buy
10,009
+6,026
+151% +$522K 0.03% 254
2024
Q3
$359K Sell
3,983
-1,522
-28% -$128K 0.02% 353
2024
Q2
$433K Sell
5,505
-11,324
-67% -$928K 0.02% 363
2024
Q1
$4.56M Buy
16,829
+9,523
+130% +$813K 0.23% 57
2023
Q4
$635K Buy
7,306
+2,721
+59% +$207K 0.03% 341
2023
Q3
$359K Sell
4,585
-66
-1% -$5.53K 0.02% 383
2023
Q2
$410K Buy
4,651
+1,400
+43% +$121K 0.02% 382
2023
Q1
$262K Buy
3,251
+265
+9% +$21.6K 0.02% 408
2022
Q4
$232K Buy
+2,986
New +$242K 0.02% 375

Other funds holding MDT

SageView Advisory Group's MDT Position: Q2 2026 in Review

SageView Advisory Group reduced its Medtronic (MDT) stake by 6.8% in Q2 2026, selling an estimated $43.6K and leaving 7,464 shares worth $584K. The position accounts for 0.02% of the portfolio, ranked #336.

SageView Advisory Group first reported a position in MDT in Q4 2022 and has held it in 15 quarters since. The position peaked at $4.56M in Q1 2024. 2,140 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • SageView Advisory Group held 7,464 shares of Medtronic worth $584K as of Q2 2026.
  • SageView Advisory Group sold 541 Medtronic shares in Q2 2026, an estimated $43.6K.
  • Medtronic made up 0.02% of SageView Advisory Group's portfolio in Q2 2026, its #336 holding.
  • SageView Advisory Group first reported a position in Medtronic in Q4 2022 and has held it in 15 quarters since.
  • SageView Advisory Group's Medtronic position peaked at $4.56M in Q1 2024.
  • 2,140 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on SageView Advisory Group's 13F filing for Q2 2026, filed 10 Aug 2026.